Clinical trial
Colony-Stimulating Factors in Treating Children With Recurrent or Refractory…
NCT00003597 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003597 |
|---|---|
| Title | Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors |
| Official title | A Phase I Study of Thrombopoietin (rhTPO) Plus G-CSF in Children Receiving Ifosfamide, Carboplatin, and Etoposide (I.C.E.) Chemotherapy for Recurrent or Refractory Solid Tumors |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Biological, Drug |
| Interventions | recombinant human thrombopoietin, carboplatin, etoposide, ifosfamide, G-CSF |
| Enrollment | 16 |
| Start date | Nov 1, 1998 |
| Primary completion | Oct 1, 2004 |
| Completion | Sep 1, 2005 |
| First posted | Apr 18, 2003 |
| Last update posted | Jul 24, 2014 |
| Countries | Australia, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: